Target intelligence / Profile preview

Adhesion G protein-coupled receptor G4 (ADGRG4)

Target
ADGRG4
Molecular classification
G protein-coupled receptor, Adhesion G protein-coupled receptor (aGPCR), 7-transmembrane domain receptor
01

Overview

Adhesion G protein-coupled receptor G4 (ADGRG4, also known as GPR112) is a member of the adhesion GPCR family characterized by large extracellular regions and a signature seven-transmembrane domain. It is an orphan receptor, as its endogenous ligand is unknown. ADGRG4 contains a unique pentraxin-like domain that may form dimers, potentially functioning as a sensor for mechanical shear forces, especially in enterochromaffin and Paneth cells of the small intestine[1][2][4]. The receptor is coupled to G(s) proteins and can activate adenylate cyclase, modulating downstream signaling pathways[4]. ADGRG4 is expressed in normal enterochromaffin cells and gastric neuroendocrine carcinoma cells, and is investigated as a potential marker and therapeutic target for these cancers[2]. ADGRG4 currently lacks well-characterized interacting drugs owing to its status as an orphan receptor, and no established endogenous ligands or antagonist/agonist pharmacology are available. Its role in disease is most recognized in neuroendocrine cancers and as a candidate immunotherapy target[2]. Mechanistically, it is believed to contribute to mechanical force sensing and classical GPCR-mediated adenylate cyclase activation[1][4].

Other names
Adhesion G protein-coupled receptor G4ADGRG4GPR112PGR17RP1-299I16probable G-protein coupled receptor 112ADGRG4 N-terminal fragmentADGRG4 C-terminal fragment
02

Mechanism of action

Coupling to G(s) proteins, mediating activation of adenylate cyclase. May act as a sensor for mechanical (shear) forces in intestinal cells.

03

Biological functions

Signal transductionTransmembrane signaling receptor activitySensing mechanical forces
04

Disease associations

Cancer (specifically neuroendocrine carcinoma)Martin-Probst Syndrome (genetic disease association)Potential biomarker or immunotherapy target for gastrointestinal neuroendocrine carcinoma
05

Biomarkers

Expression in gastrointestinal neuroendocrine carcinoma cells; considered a novel biomarker for this cancer

Beyond the preview

Go deeper on Adhesion G protein-coupled receptor G4 (ADGRG4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adhesion G protein-coupled receptor G4 (ADGRG4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call